Skip to content

Effectiveness and Changes in Brain Functions by an Occupational Therapy Program Incorporating Mindfulness in Outpatients with Anxiety and Depression: A Randomized Controlled Trial.

Atsuko Yamamoto, Banri Tsukuda, Shota Minami, Seina Hayamizu, Minami Naito, Yosuke Koshikawa, Toshiya Funatsuki, Chikashi Takano, Haruhiko Ogata, Yoshiteru Takekita, Keiichiro Nishida, Shunichiro Ikeda, Toshihiko Kinoshita, Masaki Kato

Neuropsychobiology August 10, 2023 DOI: 10.1159/000531487 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized wait-list controlled trial Peer reviewed
Sample size 25
Population Outpatients with anxiety disorders and depression (mean age 44.1)
Intervention Occupational therapy program incorporating mindfulness (MOT)
Duration 8-week intervention with assessments at baseline, 9 weeks (post-intervention), and 18 weeks (follow-up)
Measures Questionnaire about the Process of Recovery (QPR), quantitative electroencephalography (qEEG)
Topics Anxiety Depression Meditation
Keywords Brain Humans Treatment outcome Occupational therapy Anxiety disorders Adult Outpatients Recovery
Key findings MOT produced significantly greater improvement on the Questionnaire about the Process of Recovery than the wait-list control after adjusting for baseline covariates, sustained 9 weeks after the 8-week program. The MOT group also showed increased current source density in the beta-2 band of the left dorsolateral prefrontal cortex. The authors suggest MOT may be a viable option for patients with residual social and occupational impairment.

Abstract

Introduction: This study examined the efficacy of an 8-week occupational therapy program incorporating mindfulness (MOT) as a form of psychiatric rehabilitation to ameliorate residual social and occupational impairment in patients with anxiety disorders and depression. The objective was to evaluate the effects of MOT on their personal well-being and to assess the impact of MOT on brain function using quantitative electroencephalography (qEEG).

Methods: This study was a randomized, wait-list control trial with assessments performed at baseline, post-intervention (9 weeks), and follow-up (18 weeks) in outpatients with anxiety disorders and depression. The MOT was conducted in small groups, comprising eight weekly 1.5-h sessions. The primary outcome was the mean score change between the pre- and post-interventions with Questionnaire about the Process of Recovery (QPR) scale. Other clinical assessments and qEEG served as secondary and biological outcomes, respectively.

Results: A total of 25 patients (mean age: 44.1) were included in the analysis. The MOT group demonstrated a significantly improved QPR compared to the control group after adjusting for baseline covariates (p < 0.01). This improvement was sustained for 9 weeks after the 8-week intervention. In the qEEG analysis, a significant increase in current source density in the β2 band of the left dorsolateral prefrontal cortex was observed in the MOT group compared to the control group (p < 0.02).

Conclusion: This study demonstrates that MOT improves subjective well-being and potentially, global function. This suggests that MOT may serve as a viable option for those whose symptoms have abated but who still struggle with social and occupational functioning.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics